Alison Smith

1.1k total citations · 1 hit paper
23 papers, 708 citations indexed

About

Alison Smith is a scholar working on Economics and Econometrics, Otorhinolaryngology and Surgery. According to data from OpenAlex, Alison Smith has authored 23 papers receiving a total of 708 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Economics and Econometrics, 4 papers in Otorhinolaryngology and 3 papers in Surgery. Recurrent topics in Alison Smith's work include Health Systems, Economic Evaluations, Quality of Life (8 papers), Head and Neck Cancer Studies (4 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Alison Smith is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (8 papers), Head and Neck Cancer Studies (4 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Alison Smith collaborates with scholars based in United Kingdom, Australia and Canada. Alison Smith's co-authors include Peter Hall, Claire Hulme, Janet Dunn, Hisham Mehanna, Joy K Rahman, Max Robinson, A. Hartley, Christopher C. McConkey, Sandra Ventorin von Zeidler and Wai‐Lup Wong and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and British Journal of Cancer.

In The Last Decade

Alison Smith

23 papers receiving 693 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer

2016 384 citations Hisham Mehanna, Wai‐Lup Wong et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alison Smith United Kingdom	11	367	239	183	158	148	23	708
Noam A. VanderWalde United States	16	225 0.6×	247 1.0×	64 0.3×	242 1.5×	269 1.8×	48	822
Colin T. Murphy United States	12	357 1.0×	266 1.1×	78 0.4×	324 2.1×	299 2.0×	22	786
Jonathan Klein United States	14	154 0.4×	215 0.9×	168 0.9×	247 1.6×	199 1.3×	40	900
Santam Chakraborty India	15	128 0.3×	245 1.0×	107 0.6×	244 1.5×	213 1.4×	79	688
Dion Forstner Australia	16	202 0.6×	89 0.4×	278 1.5×	183 1.2×	132 0.9×	42	629
Sewit Teckie United States	15	138 0.4×	121 0.5×	72 0.4×	131 0.8×	190 1.3×	39	514
Lisa Chaiken United States	7	267 0.7×	174 0.7×	321 1.8×	158 1.0×	201 1.4×	12	672
Peijin Han United States	13	109 0.3×	76 0.3×	237 1.3×	149 0.9×	100 0.7×	44	566
Arif Jamshed Pakistan	17	246 0.7×	269 1.1×	66 0.4×	126 0.8×	327 2.2×	85	838
Amit Jethanandani United States	12	109 0.3×	74 0.3×	112 0.6×	115 0.7×	159 1.1×	28	513

Countries citing papers authored by Alison Smith

Since Specialization

Citations

This map shows the geographic impact of Alison Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Smith more than expected).

Fields of papers citing papers by Alison Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Smith. The network helps show where Alison Smith may publish in the future.

Co-authorship network of co-authors of Alison Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Smith. A scholar is included among the top collaborators of Alison Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Smith. Alison Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jones, Graham, Katy Bell, Ferruccio Ceriotti, et al.. (2024). Applying the Milan models to setting analytical performance specifications – considering all the information. Clinical Chemistry and Laboratory Medicine (CCLM). 62(8). 1531–1537. 4 indexed citations

Smith, Alison, et al.. (2022). An exploratory assessment of the impact of a novel risk assessment test on breast cancer clinic waiting times and workflow: a discrete event simulation model. BMC Health Services Research. 22(1). 1301–1301. 3 indexed citations

Messenger, Michael, et al.. (2021). Integrating Early Economic Evaluation into Target Product Profile development for medical tests: advantages and potential applications. International Journal of Technology Assessment in Health Care. 37(1). e68–e68. 4 indexed citations

Loh, Tze Ping, Alison Smith, Katy Bell, et al.. (2021). Setting analytical performance specifications using HbA1c as a model measurand. Clinica Chimica Acta. 523. 407–414. 9 indexed citations

Zheng, Pu, et al.. (2020). Simultaneous Monitoring and Comparison of Multiple Product Quality Attributes for Cell Culture Processes at Different Scales Using a LC/MS/MS Based Multi-Attribute Method. Journal of Pharmaceutical Sciences. 109(11). 3319–3329. 24 indexed citations

Smith, Alison. (2020). Political Party Membership in New Democracies. 3 indexed citations

Abel, Lucy, Bethany Shinkins, Alison Smith, et al.. (2019). Early Economic Evaluation of Diagnostic Technologies: Experiences of the NIHR Diagnostic Evidence Co-operatives. Medical Decision Making. 39(7). 857–866. 23 indexed citations

Smith, Alison, et al.. (2018). The Role of Measurement Uncertainty in Health Technology Assessments (HTAs) of In Vitro Tests. PharmacoEconomics. 36(7). 823–835. 2 indexed citations

Smith, Alison, et al.. (2017). The incorporation of data on pre-analytical and analytical factors in model-based Health Technology Assessments(HTAs) of medical tests: a systematic review protocol. RePEc: Research Papers in Economics. 1 indexed citations

10.

Smith, Alison, Peter Hall, Claire Hulme, et al.. (2017). Cost-effectiveness analysis of PET-CT-guided management for locally advanced head and neck cancer. European Journal of Cancer. 85. 6–14. 27 indexed citations

11.

Harward, Meg, Alison Smith, & Leanne M. Aitken. (2017). Inconsistent VAP definitions raise questions of usefulness. Australian Critical Care. 31(1). 54–55. 1 indexed citations

12.

Hall, Peter, Alison Smith, Claire Hulme, et al.. (2017). Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim Trial. Value in Health. 20(10). 1311–1318. 35 indexed citations

13.

Howard, Dena, Talha Munir, Lucy McParland, et al.. (2017). Clinical effectiveness and cost-effectiveness results from the randomised, Phase IIB trial in previously untreated patients with chronic lymphocytic leukaemia to compare fludarabine, cyclophosphamide and rituximab with fludarabine, cyclophosphamide, mitoxantrone and low-dose rituximab: the Attenuated dose Rituximab with ChemoTherapy In Chronic lymphocytic leukaemia (ARCTIC) trial. Health Technology Assessment. 21(28). 1–374. 16 indexed citations

14.

Rice, Stephen, Alison Smith, Mark Rodgers, et al.. (2016). The Clinical and Cost Effectiveness of Ustekinumab for the Treatment of Psoriatic Arthritis: A Critique of the Evidence. PharmacoEconomics. 34(4). 337–348. 3 indexed citations

15.

Mehanna, Hisham, Wai‐Lup Wong, Christopher C. McConkey, et al.. (2016). PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer. New England Journal of Medicine. 374(15). 1444–1454. 384 indexed citations breakdown →

16.

Hall, Peter, Patrick Hamilton, Claire Hulme, et al.. (2015). Costs of cancer care for use in economic evaluation: a UK analysis of patient-level routine health system data. British Journal of Cancer. 112(5). 948–956. 49 indexed citations

17.

Mehanna, Hisham, Wai Lup Wong, Christopher C. McConkey, et al.. (2015). PET-NECK: A multi-centre, randomized, phase III, controlled trial (RCT) comparing PETCT guided active surveillance with planned neck dissection (ND) for locally advanced (N2/N3) nodal metastases (LANM) in patients with head and neck squamous cell cancer (HNSCC) treated with primary radical chemoradiotherapy (CRT).. Journal of Clinical Oncology. 33(15_suppl). 6009–6009. 5 indexed citations

18.

Smith, Alison, Peter Hall, John O’Dwyer, et al.. (2015). Modelling cost-effectiveness and value of information in clinical trials to inform stop go decisions: results from the arctic study. Trials. 16(S2). 11 indexed citations

19.

Smith, Alison, Peter Hall, Claire Hulme, et al.. (2015). Is PET-CT guided management for patients with locally advanced head and neck squamous cell cancer (HNSCC) cost-effective? Results from a UK non-inferiority phase III randomized trial.. Journal of Clinical Oncology. 33(15_suppl). 6010–6010. 1 indexed citations

20.

Hall, Peter, Alison Smith, Claire Hulme, et al.. (2015). The use of early decision modelling and value of information analysis in an adaptive trial design: results from the OPTIMA preliminary study. Trials. 16(S2). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact